This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fondazione Telethon Ets. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Aurelien Jacob: Innovator in Gene Therapy
Introduction
Aurelien Jacob is a notable inventor based in Milan, Italy. He has made significant contributions to the field of gene therapy, particularly through his innovative research and patent work. His expertise and dedication to advancing medical science have positioned him as a key figure in his area of specialization.
Latest Patents
Aurelien Jacob holds a patent titled "Transient Inhibition of p53 in Gene Therapy." This patent represents a crucial advancement in the understanding and application of gene therapy techniques. With 1 patent to his name, Jacob's work is paving the way for new therapeutic approaches.
Career Highlights
Jacob is currently affiliated with Fondazione Telethon Ets, an organization dedicated to funding research for genetic diseases. His role at the foundation allows him to collaborate with other experts in the field and contribute to groundbreaking research initiatives. His work is characterized by a commitment to improving patient outcomes through innovative therapies.
Collaborations
Throughout his career, Aurelien Jacob has worked alongside talented colleagues, including Pietro Genovese and Giulia Schiroli. These collaborations have fostered a dynamic research environment, enabling the team to explore new ideas and push the boundaries of gene therapy.
Conclusion
Aurelien Jacob's contributions to gene therapy exemplify the impact of innovative thinking in the medical field. His patent and collaborative efforts highlight the importance of research in developing effective treatments for genetic disorders. Jacob's work continues to inspire future advancements in healthcare.